Zander R
Institut für Physiologie und Pathophysiologie, Universität Mainz.
Beitr Infusionsther. 1993;29:51-69.
For daily clinical practice an isovolemic hemodilution down to an arterial O2 content of 10 ml/dl, corresponding to a hemoglobin content of 7.5 g/dl or a hematocrit value of 22.5%, is described as a tolerable value, as long as normovolemia and normoxia (no disturbances of lung function) are guaranteed and local restrictions in perfusion (coronary or cerebral sclerosis) are excluded. This value is not derived from the mixed venous O2 status but from the situation of the myocardium as the main limiting organ for anemic hypoxemia. Compensation of anemia is regulated hemodynamically: First, by an increase in stroke volume; secondary, by an increase in heart frequency and, tertiary, by an increase in venous utilization. The last may reach 100% without any restrictions from the so-called critical mixed venous pO2 as a possible limiting factor for hemodilution.
对于日常临床实践而言,只要保证血容量正常和氧合正常(肺功能无紊乱)且排除局部灌注受限情况(冠状动脉或脑动脉硬化),等容性血液稀释至动脉血氧含量为10ml/dl(相当于血红蛋白含量为7.5g/dl或血细胞比容值为22.5%)被视为可耐受值。该值并非源自混合静脉血氧状态,而是源自作为贫血性低氧血症主要限制器官的心肌状况。贫血的代偿通过血流动力学进行调节:首先,通过增加每搏输出量;其次,通过增加心率;第三,通过增加静脉氧利用率。最后一点在没有所谓的临界混合静脉血氧分压作为血液稀释可能限制因素的任何限制情况下可达到100%。